Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management

Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), ad...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Obesity reviews Ročník 12; číslo 10; s. 829 - 840
Hlavní autoři:	van de Woestijne, A. P, Monajemi, H, Kalkhoven, E, Visseren, F. L. J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford, UK Blackwell Publishing Ltd 01.10.2011
Témata:	adipocytes adiponectin Adipose tissue Adipose Tissue - physiopathology Atherosclerosis Atherosclerosis - etiology cardiovascular diseases cholesterol complications cytokines etiology free fatty acids Humans hydrolysis hypertriglyceridemia Hypertriglyceridemia - complications Hypertriglyceridemia - physiopathology Hypertriglyceridemia - therapy hypertrophy insulin resistance leptin lifestyle lipid metabolism lipoprotein lipase lipoproteins obesity pandemic pathophysiology patients physiopathology risk risk reduction therapeutics therapy triacylglycerols triglycerides
ISSN:	1467-7881, 1467-789X, 1467-789X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), adipose tissue affects triglyceride metabolism. In obesity, adipocyte hypertrophy leads to many changes in adipocyte function and production of anti‐ and pro‐inflammatory cytokines. Furthermore, free fatty acids are released into the circulation contributing to insulin resistance. Adipose tissue dysfunction will eventually lead to abnormalities in lipid metabolism, such as hypertriglyceridemia (due to increased hepatic very‐low‐density lipoprotein production and decreased triglyceride hydrolysis), small dense low‐density lipoprotein particles, remnant lipoproteins and low high‐density lipoprotein cholesterol levels, all associated with a higher risk for the development of cardiovascular diseases. The clinical implications of elevated plasma triglycerides are still a matter of debate. Understanding the pathophysiology of adipose tissue dysfunction in obesity, which is becoming a pandemic condition, is essential for designing appropriate therapeutic interventions. Lifestyle changes are important to improve adipose tissue function in obese patients. Pharmacological interventions to improve adipose tissue function need further evaluation. Although statins are not very potent in reducing plasma triglycerides, they remain the mainstay of therapy for cardiovascular risk reduction in high‐risk patients.
AbstractList	Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), adipose tissue affects triglyceride metabolism. In obesity, adipocyte hypertrophy leads to many changes in adipocyte function and production of anti- and pro-inflammatory cytokines. Furthermore, free fatty acids are released into the circulation contributing to insulin resistance. Adipose tissue dysfunction will eventually lead to abnormalities in lipid metabolism, such as hypertriglyceridemia (due to increased hepatic very-low-density lipoprotein production and decreased triglyceride hydrolysis), small dense low-density lipoprotein particles, remnant lipoproteins and low high-density lipoprotein cholesterol levels, all associated with a higher risk for the development of cardiovascular diseases. The clinical implications of elevated plasma triglycerides are still a matter of debate. Understanding the pathophysiology of adipose tissue dysfunction in obesity, which is becoming a pandemic condition, is essential for designing appropriate therapeutic interventions. Lifestyle changes are important to improve adipose tissue function in obese patients. Pharmacological interventions to improve adipose tissue function need further evaluation. Although statins are not very potent in reducing plasma triglycerides, they remain the mainstay of therapy for cardiovascular risk reduction in high-risk patients.Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), adipose tissue affects triglyceride metabolism. In obesity, adipocyte hypertrophy leads to many changes in adipocyte function and production of anti- and pro-inflammatory cytokines. Furthermore, free fatty acids are released into the circulation contributing to insulin resistance. Adipose tissue dysfunction will eventually lead to abnormalities in lipid metabolism, such as hypertriglyceridemia (due to increased hepatic very-low-density lipoprotein production and decreased triglyceride hydrolysis), small dense low-density lipoprotein particles, remnant lipoproteins and low high-density lipoprotein cholesterol levels, all associated with a higher risk for the development of cardiovascular diseases. The clinical implications of elevated plasma triglycerides are still a matter of debate. Understanding the pathophysiology of adipose tissue dysfunction in obesity, which is becoming a pandemic condition, is essential for designing appropriate therapeutic interventions. Lifestyle changes are important to improve adipose tissue function in obese patients. Pharmacological interventions to improve adipose tissue function need further evaluation. Although statins are not very potent in reducing plasma triglycerides, they remain the mainstay of therapy for cardiovascular risk reduction in high-risk patients. Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), adipose tissue affects triglyceride metabolism. In obesity, adipocyte hypertrophy leads to many changes in adipocyte function and production of anti‐ and pro‐inflammatory cytokines. Furthermore, free fatty acids are released into the circulation contributing to insulin resistance. Adipose tissue dysfunction will eventually lead to abnormalities in lipid metabolism, such as hypertriglyceridemia (due to increased hepatic very‐low‐density lipoprotein production and decreased triglyceride hydrolysis), small dense low‐density lipoprotein particles, remnant lipoproteins and low high‐density lipoprotein cholesterol levels, all associated with a higher risk for the development of cardiovascular diseases. The clinical implications of elevated plasma triglycerides are still a matter of debate. Understanding the pathophysiology of adipose tissue dysfunction in obesity, which is becoming a pandemic condition, is essential for designing appropriate therapeutic interventions. Lifestyle changes are important to improve adipose tissue function in obese patients. Pharmacological interventions to improve adipose tissue function need further evaluation. Although statins are not very potent in reducing plasma triglycerides, they remain the mainstay of therapy for cardiovascular risk reduction in high‐risk patients. Summary Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By secreting adipokines (such as adiponectin and leptin) and other proteins (such as lipoprotein lipase and cholesteryl ester transferase protein), adipose tissue affects triglyceride metabolism. In obesity, adipocyte hypertrophy leads to many changes in adipocyte function and production of anti‐ and pro‐inflammatory cytokines. Furthermore, free fatty acids are released into the circulation contributing to insulin resistance. Adipose tissue dysfunction will eventually lead to abnormalities in lipid metabolism, such as hypertriglyceridemia (due to increased hepatic very‐low‐density lipoprotein production and decreased triglyceride hydrolysis), small dense low‐density lipoprotein particles, remnant lipoproteins and low high‐density lipoprotein cholesterol levels, all associated with a higher risk for the development of cardiovascular diseases. The clinical implications of elevated plasma triglycerides are still a matter of debate. Understanding the pathophysiology of adipose tissue dysfunction in obesity, which is becoming a pandemic condition, is essential for designing appropriate therapeutic interventions. Lifestyle changes are important to improve adipose tissue function in obese patients. Pharmacological interventions to improve adipose tissue function need further evaluation. Although statins are not very potent in reducing plasma triglycerides, they remain the mainstay of therapy for cardiovascular risk reduction in high‐risk patients.
Author	Visseren, F. L. J. van de Woestijne, A. P. Kalkhoven, E. Monajemi, H.
Author_xml	– sequence: 1 fullname: van de Woestijne, A. P – sequence: 2 fullname: Monajemi, H – sequence: 3 fullname: Kalkhoven, E – sequence: 4 fullname: Visseren, F. L. J
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/21749607$$D View this record in MEDLINE/PubMed
BookMark	eNqNkUtv1DAUhS1U1Bf9C5AdbJLacRzbCFUqFW1RqymircrOcpybqYc8BjsRk3-P05RZsEC1ZPnK_s6xdM4B2mm7FhCKCE5IWMerhGQ5j7mQP5IUE5JgLDFONq_Q_vZhZzsLsocOvF9hTLikZBftpYRnMsd8Hy1OS7vuPES99X6AqBx9NbSmt10b6baMHsc1uN7ZZT0acLaExuqPUQPmUbfWN_4JanSrl9BA279Brytdezh6Pg_R_fmXu7PL-Prm4uvZ6XVsWCpwDBQXmlZCMy1yzigngsqChk2ApobKcJdVuEgpLaqSMa41S3la8ZKYEkDSQ_R-9l277tcAvleN9QbqWrfQDV4JmQnCJOOB_PBfkuQ5zTOa5iKgb5_RoWigVGtnG-1G9TetAIgZMK7z3kG1RQhWUzFqpabM1ZS_mopRT8WoTZCe_CM1ttdTzL3Ttn6JwafZ4LetYXzxx-rm8_cwBHk8y63vYbOVa_dT5Zxyph4WF-pqcfdtcX51qx4C_27mK90pvXTWq_vbYMwwxlzmGad_APCGv-o
CitedBy_id	crossref_primary_10_1016_j_fertnstert_2016_10_027 crossref_primary_10_1016_j_ejim_2025_02_007 crossref_primary_10_3390_antiox7090120 crossref_primary_10_1007_s00125_014_3205_0 crossref_primary_10_1016_j_semcancer_2025_06_008 crossref_primary_10_3390_ijms232415530 crossref_primary_10_1080_13880209_2016_1278454 crossref_primary_10_1186_s12884_025_07761_3 crossref_primary_10_1016_j_lpm_2021_104085 crossref_primary_10_1016_j_rmed_2013_02_001 crossref_primary_10_1161_JAHA_121_023227 crossref_primary_10_2147_DMSO_S455428 crossref_primary_10_1016_j_hfc_2012_06_012 crossref_primary_10_1080_13813455_2018_1550094 crossref_primary_10_4236_cm_2013_43010 crossref_primary_10_1210_jc_2013_3918 crossref_primary_10_1007_s11892_015_0578_5 crossref_primary_10_3390_jcm8030365 crossref_primary_10_3389_fendo_2024_1366830 crossref_primary_10_1089_met_2016_0156 crossref_primary_10_1016_j_bbalip_2011_10_002 crossref_primary_10_1002_dmrr_3491 crossref_primary_10_3390_nu15112486 crossref_primary_10_1124_jpet_115_229740 crossref_primary_10_1016_j_jacl_2016_09_013 crossref_primary_10_1053_j_jrn_2018_08_011 crossref_primary_10_1111_1471_0528_13261 crossref_primary_10_1371_journal_pone_0101082 crossref_primary_10_3945_ajcn_113_063792 crossref_primary_10_1016_j_jff_2013_12_016 crossref_primary_10_1136_heartjnl_2024_324038 crossref_primary_10_3389_fneur_2019_01230 crossref_primary_10_1186_s12944_018_0814_5 crossref_primary_10_1371_journal_pone_0134893 crossref_primary_10_1186_1475_2840_10_100 crossref_primary_10_3390_ijms241411300 crossref_primary_10_1155_2014_189085 crossref_primary_10_1016_j_preghy_2021_12_012 crossref_primary_10_3390_nu14163347 crossref_primary_10_1016_j_diabres_2023_110561 crossref_primary_10_1515_med_2021_0408 crossref_primary_10_1210_clinem_dgae200 crossref_primary_10_3389_fneur_2020_574280 crossref_primary_10_3389_fmed_2022_887741 crossref_primary_10_1016_j_ijcard_2012_01_008 crossref_primary_10_1016_j_metabol_2013_07_007 crossref_primary_10_3390_nu16081143 crossref_primary_10_1111_cen_13310 crossref_primary_10_1371_journal_pone_0070257 crossref_primary_10_4103_EUS_D_21_00167 crossref_primary_10_1177_147323001204000409 crossref_primary_10_1016_j_atherosclerosissup_2015_02_011 crossref_primary_10_1111_avj_12159 crossref_primary_10_1007_s00125_018_4571_9 crossref_primary_10_3389_fendo_2023_1153072 crossref_primary_10_1080_14789450_2018_1551134 crossref_primary_10_1089_met_2013_0090 crossref_primary_10_2527_jas_2015_9150 crossref_primary_10_2147_DMSO_S454826 crossref_primary_10_3390_nu16121833 crossref_primary_10_4158_EP13155_GL crossref_primary_10_1186_s12889_022_13992_2
Cites_doi	10.1038/nrm2391 10.1161/01.ATV.0000172689.53992.25 10.1001/jama.298.3.299 10.1016/j.amjmed.2009.01.005 10.1038/ng.2007.24 10.1007/s00424-007-0301-8 10.1074/jbc.M608602200 10.1046/j.1365-2362.2002.00945.x 10.1172/JCI29881 10.2337/db06-0911 10.1097/MCO.0b013e32833bed6a 10.1016/j.atherosclerosis.2009.12.027 10.1096/fj.01-0944rev 10.2337/diabetes.54.3.795 10.1194/jlr.M600548-JLR200 10.1016/S0021-9150(00)00484-6 10.1503/cmaj.060963 10.1210/jc.2005-1895 10.1210/jc.2006-1268 10.1161/CIRCRESAHA.107.156554 10.1113/jphysiol.2001.013358 10.1194/jlr.M600153-JLR200 10.1155/2010/364957 10.1016/j.cell.2010.02.034 10.1097/01.mol.0000217892.00618.54 10.1093/clinchem/41.10.1421 10.1152/ajpendo.1996.271.5.E834 10.2337/diacare.27.7.1756 10.1053/meta.2001.24220 10.1507/endocrj.K08E-182 10.1016/S0140-6736(10)60408-4 10.1111/j.1365-2362.1994.tb00987.x 10.1161/CIRCULATIONAHA.106.622514 10.1001/archinternmed.2010.207 10.1016/j.febslet.2009.08.019 10.1126/science.1103160 10.1016/j.clinbiochem.2009.05.018 10.1152/ajpendo.1995.268.4.E588 10.1172/JCI37007 10.2337/diabetes.51.8.2467 10.1136/jcp.2008.055756 10.1172/JCI200319246 10.1210/jc.2008-1001 10.1161/ATVBAHA.109.194050 10.1161/01.RES.0000258023.76515.a3 10.1038/nature01137 10.2337/dc09-1315 10.1074/jbc.M706762200 10.1517/14740331003623218 10.1172/JCI43378 10.1038/oby.2003.74 10.1097/MOL.0b013e32814a645f 10.1038/ijo.2009.293 10.1136/bmj.38755.366331.2F 10.1161/CIRCULATIONAHA.106.637793 10.2337/db07-0882 10.1038/nrg2481 10.1073/pnas.1005259107 10.1111/j.1365-2796.1992.tb01256.x 10.1007/s00125-006-0370-9 10.1016/S0002-9343(01)01114-7 10.1161/01.CIR.0000105681.70455.73 10.1161/01.ATV.14.11.1767 10.1210/en.2007-1355 10.1161/CIRCULATIONAHA.108.784785 10.1001/jama.285.19.2486 10.1079/BJN20041213 10.1210/jc.2006-1055 10.1194/jlr.R700014-JLR200 10.2217/clp.10.43 10.1046/j.1463-1326.2002.00236.x 10.3402/fnr.v52i0.1656 10.2337/db08-1098 10.1172/JCI28898 10.1053/j.gastro.2007.03.056 10.1097/00043798-199604000-00014 10.1017/S0007114508971282 10.1210/er.20.5.649 10.1097/00008483-200211000-00002 10.1016/j.bbrc.2006.01.012 10.1074/jbc.M505818200 10.1016/j.plipres.2010.10.004 10.1001/jama.298.10.1180 10.2337/diabetes.51.5.1319 10.1001/jama.298.3.309 10.1210/jcem-59-6-1176 10.1161/01.CIR.0000145615.33955.83 10.1056/NEJMp1008233 10.1056/NEJMoa1001282 10.1161/CIRCULATIONAHA.107.724096 10.1056/NEJMoa020194 10.1016/j.it.2004.09.015 10.1210/jc.2009-0594 10.1097/MOL.0b013e32832d4a33 10.1194/jlr.R200004-JLR200 10.1001/jama.2008.621 10.2337/db08-0604 10.1016/S0021-9150(98)00051-3 10.1126/science.106.2748.190 10.1586/erc.10.4
ContentType	Journal Article
Copyright	2011 The Authors. reviews © 2011 International Association for the Study of Obesity 2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.
Copyright_xml	– notice: 2011 The Authors. reviews © 2011 International Association for the Study of Obesity – notice: 2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.
DBID	FBQ BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8
DOI	10.1111/j.1467-789X.2011.00900.x
DatabaseName	AGRIS Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic CrossRef MEDLINE AGRICOLA
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1467-789X
EndPage	840
ExternalDocumentID	21749607 10_1111_j_1467_789X_2011_00900_x OBR900 ark_67375_WNG_KNTPNFKS_W US201500079647
Genre	reviewArticle Journal Article Review
GroupedDBID	--- .3N .GA .Y3 05W 0R~ 10A 123 1OC 29N 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABJNI ABPTK ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD ESX EX3 F00 F01 F04 F5P FBQ FEDTE FUBAC G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~KM ~WT AAHBH AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIDQK AIDYY AITYG ALVPJ BSCLL HGLYW OIG AAYXX CITATION O8X CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8
ID	FETCH-LOGICAL-c5280-e30ba3f8a5a8675371839b339b1e32c397534f0b233bfd557aa5272f7d1cdee93
IEDL.DBID	DRFUL
ISICitedReferencesCount	80
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000295139400006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1467-7881 1467-789X
IngestDate	Fri Jul 11 12:31:50 EDT 2025 Fri Jul 11 18:32:13 EDT 2025 Mon Jul 21 06:04:50 EDT 2025 Sat Nov 29 03:04:33 EST 2025 Tue Nov 18 22:01:31 EST 2025 Wed Jan 22 16:49:26 EST 2025 Sun Sep 21 06:16:28 EDT 2025 Wed Dec 27 19:18:18 EST 2023
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
License	2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5280-e30ba3f8a5a8675371839b339b1e32c397534f0b233bfd557aa5272f7d1cdee93
Notes	http://dx.doi.org/10.1111/j.1467-789X.2011.00900.x istex:4BF0BCAF673E45BAD6B085AE86696C9F8120A612 ArticleID:OBR900 ark:/67375/WNG-KNTPNFKS-W ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-3
PMID	21749607
PQID	1663643268
PQPubID	24069
PageCount	12
ParticipantIDs	proquest_miscellaneous_894815957 proquest_miscellaneous_1663643268 pubmed_primary_21749607 crossref_primary_10_1111_j_1467_789X_2011_00900_x crossref_citationtrail_10_1111_j_1467_789X_2011_00900_x wiley_primary_10_1111_j_1467_789X_2011_00900_x_OBR900 istex_primary_ark_67375_WNG_KNTPNFKS_W fao_agris_US201500079647
PublicationCentury	2000
PublicationDate	October 2011
PublicationDateYYYYMMDD	2011-10-01
PublicationDate_xml	– month: 10 year: 2011 text: October 2011
PublicationDecade	2010
PublicationPlace	Oxford, UK
PublicationPlace_xml	– name: Oxford, UK – name: England
PublicationTitle	Obesity reviews
PublicationTitleAlternate	Obes Rev
PublicationYear	2011
Publisher	Blackwell Publishing Ltd
Publisher_xml	– name: Blackwell Publishing Ltd
References	Hogue JC, Lamarche B, Tremblay AJ, Bergeron J, Gagne C, Couture P. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res 2007; 48: 1336-1342. Skurk T, Berti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J et al. Triglyceride-rich lipoproteins isolated by selected-affinity antiapolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994; 14: 1767-1774. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008; 57: 2438-2444. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50: 14-27. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010; 375: 2267-2277. Ginsberg HN, Elam MB, Lovato LC, Crouse JR III, Leiter LA, Linz P et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-1574. Bouzakri K, Zierath JR. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor α induced insulin resistance. J Biol Chem 2007; 282: 7783-7789. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011; 121: 1858-1870. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008; 100: 227-235. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219. Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009; 20: 300-308. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A 2010; 107: 18226-18231. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002; 51: 1319-1336. Fojo SS, Brewer HB. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992; 231: 669-677. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009; 119: 1201-1215. Panarotto D, Remillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 2002; 32: 84-92. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation 2007; 115: 450-458. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF, Frayn KN. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 1995; 268: E588-E594. Radeau T, Malcolm R, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998; 139: 369-376. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunction linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377. Beigneux AP. GPIHBP1 and the processing of triglyceride-rich lipoproteins. Clin Lipidol 2010; 5: 575-582. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and the risk of stroke in the general population. JAMA 2008; 300: 2142-2152. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007; 298: 1180-1188. Alwaili K, Awan Z, Alshahrani A, Genest J. High-density lipoproteins and cardiovascular disease: 2010 update. Expert Rev Cardiovasc Ther 2010; 8: 413-423. Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007; 48: 2547-2559. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911. Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4: 407-414. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58: 718-725. Sharma NK, Das SK, Mondal AK, Hackney OG, Chu WS, Kern PA et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 2008; 93: 4532-4541. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686. Campbell PJ, Carlson MG, Nurjhan N. Fat metabolism in human obesity. Am J Physiol 1994; 266: E600-E605. Adiels M, Boren J, Caslake MJ, Soro A, Westerbacka J, Wennberg B et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697-1703. Calandra S, Priore OC, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 2006; 17: 122-127. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461. Satoh N, Shimatsu A, Himeno A, Sasaki Y, Yamakage H, Yamada K et al. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010; 33: e7. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009; 42: 1331-1346. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181-2190. Sharma AM, Staels B. Peroxisome proliferator-activated receptor gamma and adipose tissue - understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007; 92: 386-395. Rosen CJ. Revisiting the rosiglitazone story - lessons learned. N Engl J Med 2010; 363: 803-806. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140: 900-917. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025. Kraus WE, Houmard JA, Duscha BD. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-1492. Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, Peelman F et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 2010; 211: 1-8. Peterfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 2007; 39: 1483-1487. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-688. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11: 525-531. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002; 16: 1151-1162. Moreton JR. Atherosclerosis and alimentary hyperlipemia. Science 1947; 106: 190-191. Kolditz CI, Langin D. Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care 2010; 13: 377-381. Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X et al. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res 2008; 102: 250-256. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292. Sadur CN, Yost TJ, Eckel RH. Insulin responsiveness of adipose tissue lipoprotein lipase is delayed bu 2002; 16 2007; 39 2001; 50 2010; 13 2009; 42 2010; 107 2004; 27 2002; 51 2004; 25 2007; 100 2002; 112 2008; 9 1994; 24 2008; 149 2010; 140 2008; 300 2008; 102 2008; 100 2009; 119 2003; 112 2006; 332 2003; 11 2005; 25 2007; 455 1994; 266 2009; 58 2009; 10 1984; 59 1992; 231 2009; 94 2007; 176 2007; 132 2007; 298 2002; 540 2002; 43 2002; 420 2009; 122 2008; 118 2008; 117 2002; 347 2008; 61 2010; 5 1996; 3 2011; 121 2010; 9 2010; 8 2010; 34 2010; 33 2007; 18 2006; 91 2001; 285 2009; 20 2007; 282 2010 2006; 17 2002; 32 2010; 363 2008 2008; 57 2007; 92 2002; 4 2010; 362 1999; 20 2008; 55 1998; 139 2006; 116 2004; 109 2004; 306 2007; 56 2008; 93 2009; 29 2006; 114 2007; 115 2001; 154 1995; 41 2004; 110 2005; 280 2004; 92 2007; 117 2006; 49 1947; 106 2010; 211 2006; 47 2011; 50 2002; 22 2009; 583 2010; 375 1996; 271 2006; 341 1994; 14 2005; 54 1995; 268 2010; 170 2007; 48 e_1_2_8_49_2 e_1_2_8_45_2 e_1_2_8_26_2 e_1_2_8_68_2 e_1_2_8_9_2 National Cholesterol Education Program Working Group on Lipoprotein Measurement (e_1_2_8_79_2) 1995; 41 e_1_2_8_5_2 e_1_2_8_41_2 e_1_2_8_87_2 e_1_2_8_22_2 e_1_2_8_64_2 e_1_2_8_83_2 e_1_2_8_60_2 e_1_2_8_38_2 e_1_2_8_19_2 e_1_2_8_34_2 e_1_2_8_15_2 e_1_2_8_57_2 e_1_2_8_91_2 e_1_2_8_95_2 e_1_2_8_99_2 e_1_2_8_30_2 e_1_2_8_76_2 e_1_2_8_11_2 e_1_2_8_53_2 e_1_2_8_72_2 e_1_2_8_101_2 e_1_2_8_29_2 e_1_2_8_25_2 e_1_2_8_48_2 e_1_2_8_67_2 e_1_2_8_2_2 e_1_2_8_6_2 e_1_2_8_21_2 e_1_2_8_44_2 e_1_2_8_63_2 e_1_2_8_86_2 Campbell PJ (e_1_2_8_47_2) 1994; 266 e_1_2_8_40_2 e_1_2_8_82_2 e_1_2_8_18_2 e_1_2_8_14_2 e_1_2_8_37_2 e_1_2_8_56_2 e_1_2_8_90_2 e_1_2_8_94_2 e_1_2_8_98_2 e_1_2_8_10_2 e_1_2_8_33_2 e_1_2_8_52_2 e_1_2_8_75_2 e_1_2_8_71_2 e_1_2_8_102_2 e_1_2_8_28_2 e_1_2_8_24_2 e_1_2_8_89_2 e_1_2_8_3_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_66_2 e_1_2_8_43_2 e_1_2_8_85_2 e_1_2_8_62_2 e_1_2_8_81_2 e_1_2_8_17_2 e_1_2_8_13_2 e_1_2_8_59_2 e_1_2_8_36_2 e_1_2_8_78_2 e_1_2_8_97_2 e_1_2_8_55_2 e_1_2_8_32_2 e_1_2_8_74_2 e_1_2_8_51_2 e_1_2_8_93_2 e_1_2_8_70_2 e_1_2_8_27_2 e_1_2_8_23_2 e_1_2_8_46_2 e_1_2_8_69_2 e_1_2_8_80_2 e_1_2_8_4_2 e_1_2_8_8_2 e_1_2_8_42_2 e_1_2_8_65_2 e_1_2_8_88_2 e_1_2_8_61_2 e_1_2_8_84_2 e_1_2_8_16_2 e_1_2_8_39_2 e_1_2_8_12_2 e_1_2_8_35_2 e_1_2_8_58_2 e_1_2_8_96_2 e_1_2_8_31_2 e_1_2_8_54_2 e_1_2_8_77_2 e_1_2_8_50_2 e_1_2_8_73_2 e_1_2_8_100_2 e_1_2_8_92_2
References_xml	– reference: Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140: 900-917. – reference: Karpe F, Fielding BA, Ilic V, Macdonald IA, Summers LK, Frayn KN. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002; 51: 2467-2473. – reference: Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-688. – reference: Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006; 332: 752-760. – reference: Panarotto D, Remillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 2002; 32: 84-92. – reference: Chehab FF. Obesity and lipodystrophy - where do the circles intersect? Endocrinology 2008; 149: 925-934. – reference: Bouzakri K, Zierath JR. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor α induced insulin resistance. J Biol Chem 2007; 282: 7783-7789. – reference: Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50: 14-27. – reference: Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304. – reference: Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002; 16: 1151-1162. – reference: Kraus WE, Houmard JA, Duscha BD. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483-1492. – reference: Skurk T, Berti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033. – reference: Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. – reference: Andersson K, Karlstrom B, Freden S, Petersson H, Ohrvall M, Zethelius B. A two-year clinical lifestyle intervention program for weight loss in obesity. Food Nutr Res 2008; DOI: 10.3402/fnr.v52i0.165 – reference: Yokoyama H, Emoto M, Araki T, Fujiwara S, Motoyama K, Morioka T et al. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes. Diabetes Care 2004; 27: 1756-1758. – reference: Sharma AM, Staels B. Peroxisome proliferator-activated receptor gamma and adipose tissue - understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007; 92: 386-395. – reference: Aronne LJ, Wadden T, Isoldi KK, Woodworth KA. When prevention fails: obesity treatment strategies. Am J Med 2009; 122: S24-S32. – reference: Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58: 718-725. – reference: Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007; 18: 263-270. – reference: Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007; 298: 1180-1188. – reference: Peterfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 2007; 39: 1483-1487. – reference: Ji J, Watts GF, Johnson AG, Chan DC, Ooi EM, Rye KA et al. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics. J Clin Endocrinol Metab 2006; 91: 973-979. – reference: Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686. – reference: Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010; 375: 2267-2277. – reference: Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4: 407-414. – reference: Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009; 119: 1201-1215. – reference: Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56: 2655-2667. – reference: Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808. – reference: Trayhurn P, Wang IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355. – reference: Fojo SS, Brewer HB. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992; 231: 669-677. – reference: Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 2009; 10: 109-121. – reference: Karpe F, Fielding BA, Ardilouze JL, Ilic V, Macdonald IA, Frayn KN. Effects of insulin on adipose tissue blood flow in man. J Physiol 2002; 540: 1087-1093. – reference: Sadur CN, Yost TJ, Eckel RH. Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity. J Clin Endocrinol Metab 1984; 59: 1176-1182. – reference: McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001; 154: 229-236. – reference: Rosen CJ. Revisiting the rosiglitazone story - lessons learned. N Engl J Med 2010; 363: 803-806. – reference: Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunction linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377. – reference: Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298: 309-316. – reference: Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009; 42: 1331-1346. – reference: Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation 2007; 115: 450-458. – reference: Ardilouze JL, Fielding BA, Currie JM, Frayn KN, Karpe F. Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 2004; 109: 47-52. – reference: Beigneux AP. GPIHBP1 and the processing of triglyceride-rich lipoproteins. Clin Lipidol 2010; 5: 575-582. – reference: Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292. – reference: Satoh N, Shimatsu A, Himeno A, Sasaki Y, Yamakage H, Yamada K et al. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010; 33: e7. – reference: Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X et al. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res 2008; 102: 250-256. – reference: Kolditz CI, Langin D. Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care 2010; 13: 377-381. – reference: Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219. – reference: Moreton JR. Atherosclerosis and alimentary hyperlipemia. Science 1947; 106: 190-191. – reference: Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, Peelman F et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 2010; 211: 1-8. – reference: Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308. – reference: Xue X, Piao JH, Nakajima A, Sakon-Komazawa S, Kojima Y, Mori K et al. Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J Biol Chem 2005; 280: 33917-33925. – reference: Campbell PJ, Carlson MG, Nurjhan N. Fat metabolism in human obesity. Am J Physiol 1994; 266: E600-E605. – reference: Tan GD, Olivecrona G, Vidal H, Frayn KN, Karpe F. Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. Diabetologia 2006; 49: 2412-2418. – reference: Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G et al. Asia Pacific Cohort Studies Collaboration. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004; 110: 2678-2686. – reference: Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF, Frayn KN. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 1995; 268: E588-E594. – reference: Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461. – reference: Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K et al. Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction. Circulation 2008; 118: 731-742. – reference: Ginsberg HN, Elam MB, Lovato LC, Crouse JR III, Leiter LA, Linz P et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-1574. – reference: Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 2006; 341: 507-514. – reference: Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-1379. – reference: Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025. – reference: Durstine JL, Grandjean PW, Cox CA, Thompson PD. Lipids, lipoproteins and exercise. J Cardiopulm Rehabil 2002; 22: 385-398. – reference: Mitrou P, Boutati E, Lambadiari V, Maratou E, Komesidou V, Papakonstantinou A et al. Rates of lipid fluxes in adipose tissue in vivo after a mixed meal in morbid obesity. Int J Obes (Lond) 2010; 34: 770-774. – reference: Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI. Effects of lifestyle measures, antiobesity agents and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm 2010; DOI: 10.1155/2010/364957 – reference: Cefalu AB, Noto D, Arpi ML, Yin F, Spina R, Hilden H et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J Clin Endocrinol Metab 2009; 94: 4584-4590. – reference: Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455: 479-492. – reference: Ng TW, Watts GF, Farvid MS, Chan DC, Barrett PH. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes 2005; 54: 795-802. – reference: Shah P, Mudaliar S. Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 2010; 9: 347-354. – reference: Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007; 176: 1113-1120. – reference: Zhou H, Li Z, Hojjati MR, Jang D, Beyer TP, Cao G et al. Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. J Lipid Res 2006; 47: 2011-2019. – reference: Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and the risk of stroke in the general population. JAMA 2008; 300: 2142-2152. – reference: Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11: 525-531. – reference: Bourlier V, Zakaroff-Girard A, Miranville A, De BS, Maumus M, Sengenes C et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008; 117: 806-815. – reference: Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A 2010; 107: 18226-18231. – reference: Sharma NK, Das SK, Mondal AK, Hackney OG, Chu WS, Kern PA et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 2008; 93: 4532-4541. – reference: Hogue JC, Lamarche B, Tremblay AJ, Bergeron J, Gagne C, Couture P. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res 2007; 48: 1336-1342. – reference: Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011; 121: 1858-1870. – reference: Erridge C, Samani NJ. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 2009; 29: 1944-1949. – reference: Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336. – reference: Alwaili K, Awan Z, Alshahrani A, Genest J. High-density lipoproteins and cardiovascular disease: 2010 update. Expert Rev Cardiovasc Ther 2010; 8: 413-423. – reference: Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA et al. Triglyceride-rich lipoproteins prime aortic endothelium for inflammatory responses to TNF-α. Circ Res 2007; 100: 381-390. – reference: Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009; 20: 300-308. – reference: Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA et al. Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol 1996; 271: E834-E839. – reference: Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008; 100: 227-235. – reference: Bezaire V, Mairal A, Anesia R, Lefort C, Langin D. Chronic TNFalpha and cAMP pre-treatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis. FEBS Lett 2009; 583: 3045-3049. – reference: Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med 2010; 170: 1191-1201. – reference: National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. Clin Chem 1995; 41: 1421-1426. – reference: Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007; 48: 2547-2559. – reference: Kim SK, Kim HJ, Ahn CW, Park SW, Cho YW, Lim SK et al. Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients. Endocr J 2008; 55: 1085-1092. – reference: Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J et al. Triglyceride-rich lipoproteins isolated by selected-affinity antiapolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994; 14: 1767-1774. – reference: Calandra S, Priore OC, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 2006; 17: 122-127. – reference: Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911. – reference: Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184. – reference: Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-194. – reference: Ferns G, Keti V, Griffin B. Investigation and management of hypertriglyceridemia. J Clin Pathol 2008; 61: 1174-1183. – reference: Radeau T, Malcolm R, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998; 139: 369-376. – reference: McLaughlin T, Abbasi F, Lamendola C, Kim HS, Reaven GM. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. Metabolism 2001; 50: 819-824. – reference: Adiels M, Boren J, Caslake MJ, Soro A, Westerbacka J, Wennberg B et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697-1703. – reference: Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002; 51: 1319-1336. – reference: Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181-2190. – reference: Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008; 57: 2438-2444. – reference: Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 2006; 114: 681-687. – volume: 33 start-page: e7 year: 2010 article-title: Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone publication-title: Diabetes Care – volume: 117 start-page: 806 year: 2008 end-page: 815 article-title: Remodeling phenotype of human subcutaneous adipose tissue macrophages publication-title: Circulation – volume: 112 start-page: 298 year: 2002 end-page: 304 article-title: N‐3 polyunsaturated fatty acids in coronary heart disease: a meta‐analysis of randomized controlled trials publication-title: Am J Med – volume: 10 start-page: 109 year: 2009 end-page: 121 article-title: Plasma lipoproteins: genetic influences and clinical implications publication-title: Nat Rev Genet – volume: 50 start-page: 14 year: 2011 end-page: 27 article-title: Lipolysis – a highly regulated multi‐enzyme complex mediates the catabolism of cellular fat stores publication-title: Prog Lipid Res – volume: 50 start-page: 819 year: 2001 end-page: 824 article-title: Metabolic changes following sibutramine‐assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity publication-title: Metabolism – volume: 14 start-page: 1767 year: 1994 end-page: 1774 article-title: Triglyceride‐rich lipoproteins isolated by selected‐affinity antiapolipoprotein B immunosorption from human atherosclerotic plaque publication-title: Arterioscler Thromb – volume: 51 start-page: 1319 year: 2002 end-page: 1336 article-title: Tumor necrosis factor alpha suppresses adipocyte‐specific genes and activates expression of preadipocyte genes in 3T3‐L1 adipocytes: nuclear factor‐kappaB activation by TNF‐alpha is obligatory publication-title: Diabetes – volume: 29 start-page: 1944 year: 2009 end-page: 1949 article-title: Saturated fatty acids do not directly stimulate Toll‐like receptor signaling publication-title: Arterioscler Thromb Vasc Biol – volume: 16 start-page: 1151 year: 2002 end-page: 1162 article-title: Cellular adaptation to hypoxia: O ‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O ‐regulated gene expression publication-title: FASEB J – volume: 17 start-page: 122 year: 2006 end-page: 127 article-title: APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency publication-title: Curr Opin Lipidol – volume: 341 start-page: 507 year: 2006 end-page: 514 article-title: Macrophage‐secreted factors induce adipocyte inflammation and insulin resistance publication-title: Biochem Biophys Res Commun – year: 2008 article-title: A two‐year clinical lifestyle intervention program for weight loss in obesity publication-title: Food Nutr Res – volume: 13 start-page: 377 year: 2010 end-page: 381 article-title: Adipose tissue lipolysis publication-title: Curr Opin Clin Nutr Metab Care – volume: 540 start-page: 1087 year: 2002 end-page: 1093 article-title: Effects of insulin on adipose tissue blood flow in man publication-title: J Physiol – volume: 211 start-page: 1 year: 2010 end-page: 8 article-title: The metabolism of triglyceride‐rich lipoproteins revisited: new players, new insight publication-title: Atherosclerosis – volume: 583 start-page: 3045 year: 2009 end-page: 3049 article-title: Chronic TNFalpha and cAMP pre‐treatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis publication-title: FEBS Lett – volume: 115 start-page: 450 year: 2007 end-page: 458 article-title: Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies publication-title: Circulation – volume: 363 start-page: 803 year: 2010 end-page: 806 article-title: Revisiting the rosiglitazone story – lessons learned publication-title: N Engl J Med – volume: 298 start-page: 299 year: 2007 end-page: 308 article-title: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women publication-title: JAMA – volume: 61 start-page: 1174 year: 2008 end-page: 1183 article-title: Investigation and management of hypertriglyceridemia publication-title: J Clin Pathol – volume: 118 start-page: 731 year: 2008 end-page: 742 article-title: Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction publication-title: Circulation – volume: 56 start-page: 901 year: 2007 end-page: 911 article-title: Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation publication-title: Diabetes – volume: 231 start-page: 669 year: 1992 end-page: 677 article-title: Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C‐II publication-title: J Intern Med – volume: 25 start-page: 1697 year: 2005 end-page: 1703 article-title: Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia publication-title: Arterioscler Thromb Vasc Biol – volume: 109 start-page: 47 year: 2004 end-page: 52 article-title: Nitric oxide and beta‐adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans publication-title: Circulation – volume: 347 start-page: 1483 year: 2002 end-page: 1492 article-title: Effects of the amount and intensity of exercise on plasma lipoproteins publication-title: N Engl J Med – volume: 57 start-page: 2438 year: 2008 end-page: 2444 article-title: Increase in endoplasmic reticulum stress‐related proteins and genes in adipose tissue of obese, insulin‐resistant individuals publication-title: Diabetes – volume: 5 start-page: 575 year: 2010 end-page: 582 article-title: GPIHBP1 and the processing of triglyceride‐rich lipoproteins publication-title: Clin Lipidol – volume: 42 start-page: 1331 year: 2009 end-page: 1346 article-title: Hepatic insulin resistance, metabolic syndrome and cardiovascular disease publication-title: Clin Biochem – volume: 117 start-page: 175 year: 2007 end-page: 184 article-title: Obesity induces a phenotypic switch in adipose tissue macrophage polarization publication-title: J Clin Invest – volume: 93 start-page: 4532 year: 2008 end-page: 4541 article-title: Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects publication-title: J Clin Endocrinol Metab – volume: 59 start-page: 1176 year: 1984 end-page: 1182 article-title: Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity publication-title: J Clin Endocrinol Metab – volume: 271 start-page: E834 year: 1996 end-page: E839 article-title: Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism publication-title: Am J Physiol – volume: 116 start-page: 3015 year: 2006 end-page: 3025 article-title: TLR4 links innate immunity and fatty acid‐induced insulin resistance publication-title: J Clin Invest – volume: 282 start-page: 7783 year: 2007 end-page: 7789 article-title: MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor α induced insulin resistance publication-title: J Biol Chem – volume: 170 start-page: 1191 year: 2010 end-page: 1201 article-title: Rosiglitazone revisited: an updated meta‐analysis of risk for myocardial infarction and cardiovascular mortality publication-title: Arch Intern Med – volume: 43 start-page: 1363 year: 2002 end-page: 1379 article-title: Metabolic origins and clinical significance of LDL heterogeneity publication-title: J Lipid Res – volume: 285 start-page: 2486 year: 2001 end-page: 2497 article-title: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) publication-title: JAMA – volume: 114 start-page: 681 year: 2006 end-page: 687 article-title: Apolipoprotein CIII induces expression of vascular cell adhesion molecule‐1 in vascular endothelial cells and increases adhesion of monocytic cells publication-title: Circulation – volume: 154 start-page: 229 year: 2001 end-page: 236 article-title: Remnant‐like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study publication-title: Atherosclerosis – volume: 176 start-page: 1113 year: 2007 end-page: 1120 article-title: Hypertriglyceridemia: its etiology, effects and treatment publication-title: CMAJ – volume: 140 start-page: 900 year: 2010 end-page: 917 article-title: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease publication-title: Cell – volume: 106 start-page: 190 year: 1947 end-page: 191 article-title: Atherosclerosis and alimentary hyperlipemia publication-title: Science – volume: 55 start-page: 1085 year: 2008 end-page: 1092 article-title: Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients publication-title: Endocr J – volume: 119 start-page: 1201 year: 2009 end-page: 1215 article-title: GRP78 expression inhibits insulin and ER stress‐induced SREBP‐1c activation and reduces hepatic steatosis in mice publication-title: J Clin Invest – volume: 112 start-page: 1796 year: 2003 end-page: 1808 article-title: Obesity is associated with macrophage accumulation in adipose tissue publication-title: J Clin Invest – volume: 48 start-page: 1336 year: 2007 end-page: 1342 article-title: Evidence of increased secretion of apolipoprotein B‐48‐containing lipoproteins in subjects with type 2 diabetes publication-title: J Lipid Res – volume: 132 start-page: 2181 year: 2007 end-page: 2190 article-title: Obesity and atherogenic dyslipidemia publication-title: Gastroenterology – volume: 280 start-page: 33917 year: 2005 end-page: 33925 article-title: Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)‐dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha publication-title: J Biol Chem – volume: 8 start-page: 413 year: 2010 end-page: 423 article-title: High‐density lipoproteins and cardiovascular disease: 2010 update publication-title: Expert Rev Cardiovasc Ther – volume: 102 start-page: 250 year: 2008 end-page: 256 article-title: Spontaneous atherosclerosis in aged lipoprotein lipase‐deficient mice with severe hypertriglyceridemia on a normal chow diet publication-title: Circ Res – volume: 22 start-page: 385 year: 2002 end-page: 398 article-title: Lipids, lipoproteins and exercise publication-title: J Cardiopulm Rehabil – volume: 94 start-page: 4584 year: 2009 end-page: 4590 article-title: Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia publication-title: J Clin Endocrinol Metab – volume: 306 start-page: 457 year: 2004 end-page: 461 article-title: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes publication-title: Science – volume: 92 start-page: 386 year: 2007 end-page: 395 article-title: Peroxisome proliferator‐activated receptor gamma and adipose tissue – understanding obesity‐related changes in regulation of lipid and glucose metabolism publication-title: J Clin Endocrinol Metab – volume: 24 start-page: 188 year: 1994 end-page: 194 article-title: Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism publication-title: Eur J Clin Invest – volume: 11 start-page: 525 year: 2003 end-page: 531 article-title: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression publication-title: Obes Res – volume: 47 start-page: 2011 year: 2006 end-page: 2019 article-title: Adipose tissue‐specific CETP expression in mice: impact on plasma lipoprotein metabolism publication-title: J Lipid Res – volume: 4 start-page: 407 year: 2002 end-page: 414 article-title: Impact of weight loss on the metabolic syndrome publication-title: Diabetes Obes Metab – volume: 266 start-page: E600 year: 1994 end-page: E605 article-title: Fat metabolism in human obesity publication-title: Am J Physiol – volume: 92 start-page: 347 year: 2004 end-page: 355 article-title: Adipokines: inflammation and the pleiotropic role of white adipose tissue publication-title: Br J Nutr – volume: 56 start-page: 2655 year: 2007 end-page: 2667 article-title: Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease publication-title: Diabetes – volume: 107 start-page: 18226 year: 2010 end-page: 18231 article-title: Regional differences in cellular mechanisms of adipose tissue gain with overfeeding publication-title: Proc Natl Acad Sci U S A – volume: 122 start-page: S24 year: 2009 end-page: S32 article-title: When prevention fails: obesity treatment strategies publication-title: Am J Med – volume: 298 start-page: 309 year: 2007 end-page: 316 article-title: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women publication-title: JAMA – volume: 41 start-page: 1421 year: 1995 end-page: 1426 article-title: National Cholesterol Education Program recommendations for triglyceride measurement: executive summary publication-title: Clin Chem – volume: 298 start-page: 1180 year: 2007 end-page: 1188 article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta‐analysis of randomized trials publication-title: JAMA – volume: 54 start-page: 795 year: 2005 end-page: 802 article-title: Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B‐100 kinetics? publication-title: Diabetes – volume: 139 start-page: 369 year: 1998 end-page: 376 article-title: Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man publication-title: Atherosclerosis – volume: 110 start-page: 2678 year: 2004 end-page: 2686 article-title: Serum triglycerides as a risk factor for cardiovascular diseases in the Asia‐Pacific region publication-title: Circulation – volume: 34 start-page: 770 year: 2010 end-page: 774 article-title: Rates of lipid fluxes in adipose tissue after a mixed meal in morbid obesity publication-title: Int J Obes (Lond) – volume: 3 start-page: 213 year: 1996 end-page: 219 article-title: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high‐density lipoprotein cholesterol level: a meta‐analysis of population‐based prospective studies publication-title: J Cardiovasc Risk – volume: 27 start-page: 1756 year: 2004 end-page: 1758 article-title: Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes publication-title: Diabetes Care – volume: 455 start-page: 479 year: 2007 end-page: 492 article-title: Dysregulation of the expression and secretion of inflammation‐related adipokines by hypoxia in human adipocytes publication-title: Pflugers Arch – year: 2010 article-title: Effects of lifestyle measures, antiobesity agents and bariatric surgery on serological markers of inflammation in obese patients publication-title: Mediators Inflamm – volume: 121 start-page: 1858 year: 2011 end-page: 1870 article-title: Lipid‐induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid‐induced ceramide biosynthesis in mice publication-title: J Clin Invest – volume: 91 start-page: 973 year: 2006 end-page: 979 article-title: High‐density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics publication-title: J Clin Endocrinol Metab – volume: 48 start-page: 2547 year: 2007 end-page: 2559 article-title: Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis publication-title: J Lipid Res – volume: 375 start-page: 2267 year: 2010 end-page: 2277 article-title: Lipid‐induced insulin resistance: unravelling the mechanism publication-title: Lancet – volume: 51 start-page: 2467 year: 2002 end-page: 2473 article-title: Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity publication-title: Diabetes – volume: 149 start-page: 925 year: 2008 end-page: 934 article-title: Obesity and lipodystrophy – where do the circles intersect? publication-title: Endocrinology – volume: 58 start-page: 718 year: 2009 end-page: 725 article-title: Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response publication-title: Diabetes – volume: 100 start-page: 381 year: 2007 end-page: 390 article-title: Triglyceride‐rich lipoproteins prime aortic endothelium for inflammatory responses to TNF‐α publication-title: Circ Res – volume: 32 start-page: 84 year: 2002 end-page: 92 article-title: Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue‐specific manner publication-title: Eur J Clin Invest – volume: 49 start-page: 2412 year: 2006 end-page: 2418 article-title: Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone publication-title: Diabetologia – volume: 92 start-page: 1023 year: 2007 end-page: 1033 article-title: Relationship between adipocyte size and adipokine expression and secretion publication-title: J Clin Endocrinol Metab – volume: 282 start-page: 35279 year: 2007 end-page: 35292 article-title: A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll‐like receptors 2 and 4 and JNK‐dependent pathways publication-title: J Biol Chem – volume: 332 start-page: 752 year: 2006 end-page: 760 article-title: Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review publication-title: BMJ – volume: 39 start-page: 1483 year: 2007 end-page: 1487 article-title: Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia publication-title: Nat Genet – volume: 20 start-page: 300 year: 2009 end-page: 308 article-title: Inherited lipodystrophies and hypertriglyceridemia publication-title: Curr Opin Lipidol – volume: 268 start-page: E588 year: 1995 end-page: E594 article-title: Impaired postprandial clearance of triacylglycerol‐rich lipoproteins in adipose tissue in obese subjects publication-title: Am J Physiol – volume: 25 start-page: 677 year: 2004 end-page: 686 article-title: The chemokine system in diverse forms of macrophage activation and polarization publication-title: Trends Immunol – volume: 100 start-page: 227 year: 2008 end-page: 235 article-title: Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? publication-title: Br J Nutr – volume: 9 start-page: 347 year: 2010 end-page: 354 article-title: Pioglitazone: side effect and safety profile publication-title: Expert Opin Drug Saf – volume: 420 start-page: 333 year: 2002 end-page: 336 article-title: A central role for JNK in obesity and insulin resistance publication-title: Nature – volume: 9 start-page: 367 year: 2008 end-page: 377 article-title: Adipocyte dysfunction linking obesity to insulin resistance and type 2 diabetes publication-title: Nat Rev Mol Cell Biol – volume: 18 start-page: 263 year: 2007 end-page: 270 article-title: Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease publication-title: Curr Opin Lipidol – volume: 300 start-page: 2142 year: 2008 end-page: 2152 article-title: Nonfasting triglycerides and the risk of stroke in the general population publication-title: JAMA – volume: 20 start-page: 649 year: 1999 end-page: 688 article-title: Peroxisome proliferator‐activated receptors: nuclear control of metabolism publication-title: Endocr Rev – volume: 362 start-page: 1563 year: 2010 end-page: 1574 article-title: Effects of combination lipid therapy in type 2 diabetes mellitus publication-title: N Engl J Med – ident: e_1_2_8_45_2 doi: 10.1038/nrm2391 – ident: e_1_2_8_56_2 doi: 10.1161/01.ATV.0000172689.53992.25 – ident: e_1_2_8_6_2 doi: 10.1001/jama.298.3.299 – ident: e_1_2_8_86_2 doi: 10.1016/j.amjmed.2009.01.005 – ident: e_1_2_8_100_2 doi: 10.1038/ng.2007.24 – ident: e_1_2_8_22_2 doi: 10.1007/s00424-007-0301-8 – ident: e_1_2_8_52_2 doi: 10.1074/jbc.M608602200 – ident: e_1_2_8_61_2 doi: 10.1046/j.1365-2362.2002.00945.x – ident: e_1_2_8_39_2 doi: 10.1172/JCI29881 – ident: e_1_2_8_20_2 doi: 10.2337/db06-0911 – ident: e_1_2_8_44_2 doi: 10.1097/MCO.0b013e32833bed6a – ident: e_1_2_8_11_2 doi: 10.1016/j.atherosclerosis.2009.12.027 – ident: e_1_2_8_21_2 doi: 10.1096/fj.01-0944rev – ident: e_1_2_8_50_2 doi: 10.2337/diabetes.54.3.795 – ident: e_1_2_8_57_2 doi: 10.1194/jlr.M600548-JLR200 – ident: e_1_2_8_75_2 doi: 10.1016/S0021-9150(00)00484-6 – ident: e_1_2_8_13_2 doi: 10.1503/cmaj.060963 – ident: e_1_2_8_77_2 doi: 10.1210/jc.2005-1895 – ident: e_1_2_8_55_2 doi: 10.1210/jc.2006-1268 – ident: e_1_2_8_12_2 doi: 10.1161/CIRCRESAHA.107.156554 – ident: e_1_2_8_64_2 doi: 10.1113/jphysiol.2001.013358 – ident: e_1_2_8_70_2 doi: 10.1194/jlr.M600153-JLR200 – ident: e_1_2_8_80_2 doi: 10.1155/2010/364957 – ident: e_1_2_8_24_2 doi: 10.1016/j.cell.2010.02.034 – ident: e_1_2_8_102_2 doi: 10.1097/01.mol.0000217892.00618.54 – volume: 41 start-page: 1421 year: 1995 ident: e_1_2_8_79_2 article-title: National Cholesterol Education Program recommendations for triglyceride measurement: executive summary publication-title: Clin Chem doi: 10.1093/clinchem/41.10.1421 – ident: e_1_2_8_66_2 doi: 10.1152/ajpendo.1996.271.5.E834 – ident: e_1_2_8_81_2 doi: 10.2337/diacare.27.7.1756 – ident: e_1_2_8_82_2 doi: 10.1053/meta.2001.24220 – ident: e_1_2_8_48_2 doi: 10.1507/endocrj.K08E-182 – ident: e_1_2_8_51_2 doi: 10.1016/S0140-6736(10)60408-4 – ident: e_1_2_8_68_2 doi: 10.1111/j.1365-2362.1994.tb00987.x – ident: e_1_2_8_73_2 doi: 10.1161/CIRCULATIONAHA.106.622514 – ident: e_1_2_8_91_2 doi: 10.1001/archinternmed.2010.207 – ident: e_1_2_8_46_2 doi: 10.1016/j.febslet.2009.08.019 – ident: e_1_2_8_26_2 doi: 10.1126/science.1103160 – ident: e_1_2_8_53_2 doi: 10.1016/j.clinbiochem.2009.05.018 – ident: e_1_2_8_58_2 doi: 10.1152/ajpendo.1995.268.4.E588 – ident: e_1_2_8_27_2 doi: 10.1172/JCI37007 – ident: e_1_2_8_65_2 doi: 10.2337/diabetes.51.8.2467 – ident: e_1_2_8_94_2 doi: 10.1136/jcp.2008.055756 – ident: e_1_2_8_16_2 doi: 10.1172/JCI200319246 – ident: e_1_2_8_28_2 doi: 10.1210/jc.2008-1001 – ident: e_1_2_8_34_2 doi: 10.1161/ATVBAHA.109.194050 – ident: e_1_2_8_71_2 doi: 10.1161/01.RES.0000258023.76515.a3 – ident: e_1_2_8_25_2 doi: 10.1038/nature01137 – ident: e_1_2_8_37_2 doi: 10.2337/dc09-1315 – ident: e_1_2_8_31_2 doi: 10.1074/jbc.M706762200 – ident: e_1_2_8_93_2 doi: 10.1517/14740331003623218 – ident: e_1_2_8_35_2 doi: 10.1172/JCI43378 – ident: e_1_2_8_17_2 doi: 10.1038/oby.2003.74 – ident: e_1_2_8_49_2 doi: 10.1097/MOL.0b013e32814a645f – ident: e_1_2_8_59_2 doi: 10.1038/ijo.2009.293 – ident: e_1_2_8_97_2 doi: 10.1136/bmj.38755.366331.2F – ident: e_1_2_8_5_2 doi: 10.1161/CIRCULATIONAHA.106.637793 – ident: e_1_2_8_83_2 doi: 10.2337/db07-0882 – ident: e_1_2_8_14_2 doi: 10.1038/nrg2481 – ident: e_1_2_8_15_2 doi: 10.1073/pnas.1005259107 – ident: e_1_2_8_98_2 doi: 10.1111/j.1365-2796.1992.tb01256.x – ident: e_1_2_8_62_2 doi: 10.1007/s00125-006-0370-9 – ident: e_1_2_8_96_2 doi: 10.1016/S0002-9343(01)01114-7 – ident: e_1_2_8_63_2 doi: 10.1161/01.CIR.0000105681.70455.73 – ident: e_1_2_8_74_2 doi: 10.1161/01.ATV.14.11.1767 – ident: e_1_2_8_10_2 doi: 10.1210/en.2007-1355 – ident: e_1_2_8_72_2 doi: 10.1161/CIRCULATIONAHA.108.784785 – ident: e_1_2_8_78_2 doi: 10.1001/jama.285.19.2486 – ident: e_1_2_8_18_2 doi: 10.1079/BJN20041213 – ident: e_1_2_8_36_2 doi: 10.1210/jc.2006-1055 – ident: e_1_2_8_43_2 doi: 10.1194/jlr.R700014-JLR200 – ident: e_1_2_8_101_2 doi: 10.2217/clp.10.43 – ident: e_1_2_8_85_2 doi: 10.1046/j.1463-1326.2002.00236.x – ident: e_1_2_8_89_2 doi: 10.3402/fnr.v52i0.1656 – ident: e_1_2_8_23_2 doi: 10.2337/db08-1098 – ident: e_1_2_8_32_2 doi: 10.1172/JCI28898 – ident: e_1_2_8_84_2 doi: 10.1053/j.gastro.2007.03.056 – ident: e_1_2_8_3_2 doi: 10.1097/00043798-199604000-00014 – ident: e_1_2_8_19_2 doi: 10.1017/S0007114508971282 – ident: e_1_2_8_41_2 doi: 10.1210/er.20.5.649 – ident: e_1_2_8_87_2 doi: 10.1097/00008483-200211000-00002 – ident: e_1_2_8_33_2 doi: 10.1016/j.bbrc.2006.01.012 – ident: e_1_2_8_30_2 doi: 10.1074/jbc.M505818200 – ident: e_1_2_8_42_2 doi: 10.1016/j.plipres.2010.10.004 – ident: e_1_2_8_92_2 doi: 10.1001/jama.298.10.1180 – ident: e_1_2_8_54_2 doi: 10.2337/diabetes.51.5.1319 – ident: e_1_2_8_7_2 doi: 10.1001/jama.298.3.309 – ident: e_1_2_8_60_2 doi: 10.1210/jcem-59-6-1176 – ident: e_1_2_8_4_2 doi: 10.1161/01.CIR.0000145615.33955.83 – ident: e_1_2_8_90_2 doi: 10.1056/NEJMp1008233 – volume: 266 start-page: E600 year: 1994 ident: e_1_2_8_47_2 article-title: Fat metabolism in human obesity publication-title: Am J Physiol – ident: e_1_2_8_95_2 doi: 10.1056/NEJMoa1001282 – ident: e_1_2_8_40_2 doi: 10.1161/CIRCULATIONAHA.107.724096 – ident: e_1_2_8_88_2 doi: 10.1056/NEJMoa020194 – ident: e_1_2_8_38_2 doi: 10.1016/j.it.2004.09.015 – ident: e_1_2_8_99_2 doi: 10.1210/jc.2009-0594 – ident: e_1_2_8_9_2 doi: 10.1097/MOL.0b013e32832d4a33 – ident: e_1_2_8_67_2 doi: 10.1194/jlr.R200004-JLR200 – ident: e_1_2_8_8_2 doi: 10.1001/jama.2008.621 – ident: e_1_2_8_29_2 doi: 10.2337/db08-0604 – ident: e_1_2_8_69_2 doi: 10.1016/S0021-9150(98)00051-3 – ident: e_1_2_8_2_2 doi: 10.1126/science.106.2748.190 – ident: e_1_2_8_76_2 doi: 10.1586/erc.10.4
SSID	ssj0017931
Score	2.3117764
SecondaryResourceType	review_article
Snippet	Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By... Summary Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases....
SourceID	proquest pubmed crossref wiley istex fao
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	829
SubjectTerms	adipocytes adiponectin Adipose tissue Adipose Tissue - physiopathology Atherosclerosis Atherosclerosis - etiology cardiovascular diseases cholesterol complications cytokines etiology free fatty acids Humans hydrolysis hypertriglyceridemia Hypertriglyceridemia - complications Hypertriglyceridemia - physiopathology Hypertriglyceridemia - therapy hypertrophy insulin resistance leptin lifestyle lipid metabolism lipoprotein lipase lipoproteins obesity pandemic pathophysiology patients physiopathology risk risk reduction therapeutics therapy triacylglycerols triglycerides
Title	Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management
URI	https://api.istex.fr/ark:/67375/WNG-KNTPNFKS-W/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1467-789X.2011.00900.x https://www.ncbi.nlm.nih.gov/pubmed/21749607 https://www.proquest.com/docview/1663643268 https://www.proquest.com/docview/894815957
Volume	12
WOSCitedRecordID	wos000295139400006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1467-789X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017931 issn: 1467-7881 databaseCode: DRFUL dateStart: 20000101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swED_WdIy9rPuu2614MPbmYUlWJPWt-8gG7bzSNmvehGzLW1njlDgd7X-_O9sxhHVQxh4MButkdB_S76S7E8BrM0yGLMviyDmRR0mRs8gImUSywOXZI4bOmgDZbwcqTfVkYg67-CfKhWnrQ_QbbmQZzXxNBu6y-k8jV9pMukqcsYnjt4gn1zmqsRzA-oej0figP1NATWRtrhFRabYa13NjXyuL1VrpZghhiftXN-HRVXjbrE-jjf85sofwoEOp4V6rVo_gjq8ew70v3Tn8E0j3irOLWe3DRSO3sLiuaYEkIYeuKsIf6N3OF-j4n1_nqOIUge92w6mnNOOzelo3jaZ95M1TGI8-nrz_HHU3M0S55DqOvIgzJ0rtpNPocQhFOCsT-DAveC4oWzcp44wLkZUodeWc5IqXqmB54b0Rz2BQzSq_CWFWxgVSJVJ6kRjNjculEbpQskxKwYYBqKUIbN6VLafbM87tivuiLLHLErtswy57FQDrKS_a0h23oNlEKVv3HWdYOz7mtB-EKIrSdQN404i-78vNf1JUnJL2NP1k99OTw3S0f2xPA3i11A2LtkoHMK7ys8vaMoR3iAD5UAcQ_qWNbsrnGIn_e97qVf9D8h7R4cQvslGfW4_Kfn13hC9b_0i3Dff5MvKRvYDBYn7pX8Ld_Bfq2HwH1tRE73TG9hvQjyKE
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgQ7AXfsMCA4KEeMsU23Ft8zYYZahdmLaW9c1yYgemrenUdGj777lL0kgVQ5oQD5EiJecovu_s7-y7MyHvdC_p0SyLI2t5HiUup5HmIomEg-nZA4fO6gDZ70OZpmoy0QftcUCYC9PUh-gW3NAy6vEaDRwXpP-0cqn0pC3FGes43gZCuZ4AqgDu67uH_fGw21QAKNIm2QilFF0N7Lm2rZXZ6nZhZ8BhsfsvryOkq_y2nqD6D_7rrz0k91ueGu40wHpEbvnyMbm73-7EPyHpjjs5n1U-XNSaC91VhVMkqjm0pQt_gn87X4Drf3aVA8gxBt9-CKceE41PqmlVvzTtYm-eknH_8-jTXtSezRDlgqk48jzOLC-UFVaBz8ElMq2Mw0U9ZznHfN2kiDPGeVaA3qW1gklWSEdz573mz8haOSv9JgmzInYglQjheaIV0zYXmisnRZEUnPYCIpc6MHlbuBzPzzgzKw6MNNhdBrvL1N1lLgNCO8nzpnjHDWQ2Qc3G_oAx1oyPGK4IAY_ChN2AvK9137Vl56cYFyeFOU6_mEE6Okj7gyNzHJC3S3AYsFbcgrGln11UhgLBAw7Ieiog4V_eUXUBHS3ge88bYHUfRP8RXE54Imr83PivzLePh3Dz4h_l3pB7e6P9oRl-TQcvyQZbxkHSLbK2mF_4V-RO_gvwNn_d2txvb-0ljA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELegQ9NexjfL-AoS4i0ojuPa5m0wAqglVNvK-mY5sbNNW9Oq6dD233OXpJEqhjQhHiJFis-R78P-nX13JuSt6sd9mmVhYAzLg9jmNFCMxwG3sDw7wNBZHSD7cyjSVE4matReB4S5ME19iG7DDS2jnq_RwN3cFn9auZBq0pbiDFUYvgdAuRHjnTI9srF_kIyH3aECqCJtko2QStL1wJ4b-1pbre4WZgYYFtl_dRMgXce39QKV3P-vQ3tAtluc6u81ivWQ3HHlI7L5vT2Jf0zSPXs2n1XOX9aS8-11hUskitk3pfVPwb9dLMH1v7jOQckxBt988KcOE43PqmlVN5p2sTdPyDj5fPTpa9DezRDkPJJh4FiYGVZIw40En4MJRFoZg4c6FuUM83XjIswixrIC5C6M4ZGICmFpbp1T7CnplbPS7RA_K0ILVDHnjsVKRsrkXDFpBS_igtG-R8RKBjpvC5fj_RkXes2BERrZpZFdumaXvvII7SjnTfGOW9DsgJi1OYE5Vo8PI9wRAhyFCbseeVfLvuvLLM4xLk5wfZx-0YP0aJQmg0N97JE3K-XQYK14BGNKN7usNAWABxgw6kuP-H9pI-sCOorD_541itX9EP1HcDnhC6_159aj0j8-HsDL7j_SvSabo_1ED7-lg-dkK1qFQdIXpLdcXLqX5F7-C9Rt8ao1ud_AXCUH
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adipose+tissue+dysfunction+and+hypertriglyceridemia%3A+mechanisms+and+management&rft.jtitle=Obesity+reviews&rft.au=van+de+Woestijne%2C+A+P&rft.au=Monajemi%2C+H&rft.au=Kalkhoven%2C+E&rft.au=Visseren%2C+F+L+J&rft.date=2011-10-01&rft.eissn=1467-789X&rft.volume=12&rft.issue=10&rft.spage=829&rft_id=info:doi/10.1111%2Fj.1467-789X.2011.00900.x&rft_id=info%3Apmid%2F21749607&rft.externalDocID=21749607
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1467-7881&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1467-7881&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1467-7881&client=summon